No summary available
Searching for Solutions
These findings emphasize the need for targeted, system-level strategies to improve access, adherence, and coordinated care for individuals with schizophrenia within Medicaid programs.
The Board of Pharmacy Specialties (BPS) is now accepting applications for the 2027 BPS Ambassador Program. Board-certified pharmacists interested can apply until June 12, 2026.
No summary available
21.25
hours
hours
Expires:
04/21/2029
No summary available
1
hour
hour
Expires:
06/01/2029
No summary available
1
hour
hour
Expires:
06/01/2029
Planning to sit for the BCPP exam? We've got resources! #BCPP #AAPP #examprep #psychpharmacy
No summary available
AAPP members have developed tools and toolkits for the benefit of fellow psychiatric pharmacists and to further the knowledge of other pharmacists and health care professionals. You are encouraged to share these to educate others and highlight the value of psychiatric pharmacists. For practice-related resources, explore the Employer Resource Center.
If you are a pharmacist, practitioner, physician, educator, scientist, administrator, resident/fellow or student involved in the pharmaceutical care of individuals living with psychiatric and/or substance use disorders or have an interest in this area, we invite you to join the American Association of Psychiatric Pharmacists (AAPP).
No summary available
Find more information about a specific future annual meeting below. AAPP 2026 Annual Meeting Hyatt Regency Bellevue April 19-22, 2026 On Seattle's Eastside, Bellevue, WA AAPP 2027 Annual Meeting The Galt House April 4-7, 2027 Louisville, KY
Alleviate confusion about the use of buprenorphine and methadone in acute care settings through AAPP’s toolkit.
No summary available
No summary available
Dr. Shaina Musco, PharmD, offers suggestions to new residents on how to navigate their new position.
No summary available
Get a better understanding of LAIs and LAI use in this webinar: Introduction to Long-Acting Injectable Antipsychotics and Patient Selection. This is one of six modules in our complimentary Psychotropic LAI Training Program. Register today and get access to the full program and LAI resources!
Taylor A. Nichols, PharmD, BCPP Clinical Pharmacist Practitioner - Mental Health/Substance Use Disorders Phoenix VA Health Care System Phoenix, AZ
This webinar focuses on the CATCH cluster-randomized trial, which was conducted in 6 New York City public hospitals. The study’s Principal Investigator will give an overview of the significance of addiction consult services and the origins of the study, and then present quantitative and qualitative findings from the study.
This session reviews practical, evidence-based approaches for bringing overdose prevention and opioid use disorder (OUD) treatment into pediatric primary care. It will cover screening and risk assessment, brief counseling to reduce the consequences of drug use, naloxone distribution, and pathways for initiating and managing medications for OUD (including buprenorphine).
This award will recognize individual AAPP member efforts and accomplishments in increasing patient access to high quality mental health care in exceptional and distinctive ways. This may include activities that increase access to psychiatric pharmacist-led interprofessional care. Examples include reduction and/or mitigation of social determinants of health for people living with mental illness, increased access to novel treatments and/or clinical interventions through research, etc.
This award will recognize individual AAPP members who impact change by benefiting access to care for individuals living with mental illness and/or by advancing the profession of psychiatric pharmacy through advocacy with policymakers and/or decision-makers.